Transcatheter aortic valve implantation (TAVI) has matured into a standard treatment option
for patients with severe symptomatic aortic valve stenosis (AS) across the whole spectrum of …

Transcatheter aortic valve replacement (TAVR) is increasingly being performed in younger
and lower surgical risk patients. Given the longer life expectancy of these patients, the …

Objectives This study sought to determine the degree of Evolut (Medtronic) leaflet pinning,
diameter expansion, leaflet overhang, and performance at different implant depths of the …

Recent guidelines on valvular heart disease in Europe and the United States have
expanded the indications for transcatheter aortic valve implantation (TAVI) to younger …

Aortic stenosis is the most common valvular disease requiring valve replacement. Valve
replacement therapies have undergone progressive evolution since the 1960s. Over the last …

Since the first-in-human procedure in 2002, transcatheter aortic valve implantation (TAVI)
has become a well-established therapeutic option for severe aortic stenosis, and is offered …

Biomaterials, when implanted in the human body, can induce a series of cell-and cytokine-
related reactions termed foreign body reactions (FBRs). In the progression of FBRs …

Transcatheter heart valves (THVs) have the potential to degenerate and may require
reintervention. In the case of redo transcatheter aortic valve replacement for failed THV, the …

Objective. Valve-in-valve transcatheter aortic valve implantation (ViV-TAVI) has emerged as
a useful alternative intervention to redo-surgical aortic valve replacement (Redo-SVAR) for …

BACKGROUND: Our aim was to assess the feasibility of repeat transcatheter aortic valve
(TAV) replacement for degenerated Sapien3 (S3) prostheses by simulating subsequent …